AzTrials
AzTrials

Total Hip Arthroplasty (THA)PAINGPTNCT07012577

Observational Study on AI Accuracy in Diagnosing and Treating Failed or Painful Hip Arthroplasty

An observational study of Total Hip Arthroplasty (THA), run by Istituto Ortopedico Rizzoli at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Primary Goal: This study aims to evaluate the diagnostic and therapeutic accuracy of GPT-4 (an advanced AI language model) compared to three orthopedic surgeons with varying experience levels in cases of failed or painful total hip arthroplasty. Read more about this study

Who is it for?
Ages 18 to 80 years
Conditions the study is for
Total Hip Arthroplasty (THA)
What is being tested?
GPT-4 Assessment, Arthroplasty Fellow Assessment and Specializing Resident (4th year) Assessment
How many people
20 participants
Where
1 siteItaly
Study dates
31 May 2025to 1 Jul 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This study evaluated 20 anonymized cases of failed/painful total hip arthroplasty (2004-2024) from a tertiary center. Cases were selected for diagnostic clarity (e.g., aseptic loosening, periprosthetic fracture) and excluded if records were incomplete or ambiguous. Two senior surgeons verified case eligibility. Each case was assessed by GPT-4, an arthroplasty fellow, a 4th-year resident, and a 3rd-year resident for diagnostic/therapeutic accuracy.

Who may be able to join

  • Adults (≥18 and ≤80 years old).
  • Documented painful or failed total hip arthroplasty requiring clinical/radiological evaluation (2004-2024).
  • Complete pre-operative clinical history, imaging (X-ray/tomography), and surgical reports.
  • Clear diagnosis of failure mode (e.g., aseptic loosening, infection, fracture, wear).
  • Treatment and outcomes fully documented in the institutional database.
  • "Exemplary" cases with minimal diagnostic ambiguity (per Engh/MusculoSkleletal Infection Society criteria, etc.).

Who cannot join

  • total hip arthroplasty with no documented failure/pain (well-functioning implants).
  • Incomplete clinical/radiological records (e.g., missing pre-operative imaging or surgical notes).
  • Complex/multifactorial failures (e.g., concurrent infection + loosening + fracture).
  • Radiographs/images non-interpretable (poor quality, missing views).
  • Cases with conflicting diagnoses/treatments in original records.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • SC Ortopedia e Traumatologia e Chirurgia Protesica e dei Reimpianti di Anca e Ginocchio, IRCCS Istituto Ortopedico Rizzoli

    Bologna, Italy, 40136

Other trials in Italy

About this study

Official title: Observational Study on the Accuracy and Completeness of General Artificial Intelligence in the Diagnosis and Therapeutic Recommendations for Failed or Painful Total Hip Arthroplasty

Primary Goal:

This study aims to evaluate the diagnostic and therapeutic accuracy of GPT-4 (an advanced AI language model) compared to three orthopedic surgeons with varying experience levels in cases of failed or painful total hip arthroplasty.

Read more

Key Research Questions:

Diagnostic Accuracy:

Does GPT-4 provide correct, partially correct, or incorrect diagnoses compared to human orthopaedic surgeons?

Diagnostic Completeness:

Are GPT-4's diagnostic suggestions complete, partially complete, or incomplete compared to those of orthopedic surgeons?

Treatment Accuracy:

Does GPT-4 recommend correct, partially correct, or incorrect treatments for failed hip arthroplasty?

Treatment Completeness:

Are GPT-4's treatment recommendations fully comprehensive, partially complete, or incomplete compared to those of orthopaedic surgeon?

Study Design:

Participants:

20 anonymized patient cases (ages 18-80) with failed or painful hip arthroplasties, treated at IRCCS Istituto Ortopedico Rizzoli (Bologna, Italy) between 2004-2024.

Cases were selected based on clear diagnostic and treatment records (no ambiguous or incomplete data).

Comparison Groups:

GPT-4 (via ChatGPT interface)

Three orthopedic doctors (with different experience levels: resident, specialist, senior surgeon)

Method:

Each case (clinical summary + X-ray image) is presented to GPT-4 and the three doctors.

They must provide a diagnosis and treatment recommendations.

Two independent evaluators (principal investigator + department head) blindly assess responses for correctness and completeness using a 3-point scale (0=wrong/incomplete, 2=correct/complete).

Statistical analysis compares GPT-4 vs. human performance.

Expected Outcomes:

Determine if AI can match or outperform doctors in diagnosing and treating hip arthroplasty failures.

Assess whether GPT-4 could serve as a supplementary tool in orthopedic decision-making.

Ethical \& Privacy Considerations:

No real-time patient data is used-only anonymized past cases.

No personal/sensitive data is shared with OpenAI (GPT-4 is used via a standard web interface).

Study complies with GDPR, HIPAA, and ethical AI guidelines.

Timeline:

Study duration: ~8 months (from ethics approval to final analysis).

Results will be published regardless of outcome.

Why This Study Matters:

First study evaluating GPT-4's role in complex orthopedic diagnostics.

Could influence future AI-assisted clinical decision-making in joint replacement surgeries.

Being tested
GPT-4 Assessment, Arthroplasty Fellow Assessment, Specializing Resident (4th year) Assessment, Junior Resident (3rd year) Assessment
Keywords
Artificial intelligence, total hip arthroplasty, diagnosis, treatment
Medical subject headings
Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • GPT-4 AssessmentOther

    Diagnostic/Prognostic evaluation of any single case provided by AI (GPT-4). GPT-4 provides diagnosis/treatment recommendations via standardized prompts

  • Arthroplasty Fellow AssessmentOther

    Diagnostic/Prognostic evaluation of any single case provided by an human expert

  • Specializing Resident (4th year) AssessmentOther

    Diagnostic/Prognostic evaluation of any single case provided by an human expert

  • Junior Resident (3rd year) AssessmentOther

    Diagnostic/Prognostic evaluation of any single case provided by an human expert

Study groups in NCT07012577
Study groupRoleWhat they receive
Failed or Painful Total Hip Arthroplasty PatientsPatients with documented failed/painful THA (aseptic loosening, infection, fracture, etc.) selected from a tertiary center database (2004-2024).
Receives: Other: GPT-4 Assessment; Other: Arthroplasty Fellow Assessment; Other: Specializing Resident (4th year) Assessment; Other: Junior Resident (3rd year) Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Diagnostic correctness

    Proportion of fully correct diagnoses (score=2) by each rater, Scale 0 (worst outcome) - 2 (best outcome). 0: incorrect, 1: imprecise, 2: correct

    Measured: Immediate (post-case evaluation)

  2. Diagnostic completeness

    Proportion of fully complete diagnoses (score=2). Scale 0 (worst outcome) - 2 (best outcome). 0: incomplete, 1: partially complete, 2: complete

    Measured: Immediate (post-case evaluation)

  3. Treatment recommendation correctness

    Proportion of fully correct treatments (score=2) by each rater. Scale 0 (worst outcome) - 2 (best outcome). 0: incorrect, 1: imprecise, 2: correct

    Measured: Immediate (post-case evaluation)

  4. Treatmetn recommendation completeness

    Proportion of fully complete treatments (score=2). Scale 0 (worst outcome) - 2 (best outcome). 0: incomplete, 1: partially complete, 2: complete

    Measured: Immediate (post-case evaluation)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jun 2025
  2. Study start31 May 2025
  3. Primary completion30 Jun 2025
  4. Study completion1 Jul 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07012577
Sponsor's protocol ID
203/2025/Oss/IOR
Acronym
PAINGPT
Status last verified
May 2026
First submitted
31 May 2025
Last updated
27 May 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Rater evaluations on clinical cases; no direct patient data are included; all datasets are anonymized and do not allow identification.

Publications

  • Knee CJ, Campbell RJ, Graham DJ, Handford C, Symes M, Sivakumar BS. Examining the role of ChatGPT in the management of distal radius fractures: insights into its accuracy and consistency. ANZ J Surg. 2024 Jul-Aug;94(7-8):1391-1396. doi: 10.1111/ans.19143. Epub 2024 Jul 5.

    PubMed 38967407
  • Dagher T, Dwyer EP, Baker HP, Kalidoss S, Strelzow JA. "Dr. AI Will See You Now": How Do ChatGPT-4 Treatment Recommendations Align With Orthopaedic Clinical Practice Guidelines? Clin Orthop Relat Res. 2024 Dec 1;482(12):2098-2106. doi: 10.1097/CORR.0000000000003234. Epub 2024 Sep 6.

    PubMed 39246048
  • Artioli E, Veronesi F, Mazzotti A, Brogini S, Zielli SO, Giavaresi G, Faldini C. Assessing ChatGPT responses to common patient questions regarding total ankle arthroplasty. J Exp Orthop. 2024 Dec 31;12(1):e70138. doi: 10.1002/jeo2.70138. eCollection 2025 Jan.

    PubMed 39741912
  • Pagano S, Strumolo L, Michalk K, Schiegl J, Pulido LC, Reinhard J, Maderbacher G, Renkawitz T, Schuster M. Evaluating ChatGPT, Gemini and other Large Language Models (LLMs) in orthopaedic diagnostics: A prospective clinical study. Comput Struct Biotechnol J. 2024 Dec 26;28:9-15. doi: 10.1016/j.csbj.2024.12.013. eCollection 2025.

    PubMed 39850460

Questions about this trial

What is this clinical trial studying?

An observational study of Total Hip Arthroplasty (THA), run by Istituto Ortopedico Rizzoli at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Diagnostic correctness (time frame: Immediate (post-case evaluation)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07012577, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in